How to Get Mounjaro Prescribed for Weight Loss

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, originally developed for type 2 diabetes under the brand name Mounjaro, has emerged as a powerful option for weight management in adults with obesity or overweight conditions. The medication works by activating two separate hormone pathways that regulate appetite and glucose metabolism, leading to sustained weight reductions of 20% or more in clinical populations. PlexusDx connects eligible patients with licensed compounding pharmacies that produce tirzepatide-based therapies tailored to individual health profiles.

Understanding How Tirzepatide Works for Weight Loss

Tirzepatide functions as a dual receptor agonist, meaning it activates both GLP-1 and GIP signaling pathways simultaneously. This dual mechanism distinguishes it from single-pathway medications and contributes to its clinical efficacy. In the SURMOUNT clinical trials, participants on tirzepatide achieved average weight reductions of 20.9% over 72 weeks compared to 2.6% in the placebo group. The medication reduces hunger signals, increases feelings of fullness, and slows stomach emptying to help patients maintain caloric deficits more naturally.

The GLP-1 receptor activation mimics the body's natural appetite-suppressing hormone, while GIP activation enhances metabolic rate and energy expenditure. Together, these pathways create a compounding effect that many single-agent therapies cannot replicate. Patients typically report reduced cravings, smaller portion sizes, and decreased interest in high-calorie foods within the first two to three weeks of treatment. This neurobiological shift forms the foundation of sustainable long-term weight management.

Who Qualifies for Tirzepatide Therapy Through PlexusDx

PlexusDx evaluates patient eligibility based on BMI, weight loss history, and metabolic health markers rather than insurance status. Adults with a BMI of 27 or higher who have weight-related health conditions, or those with a BMI of 30 or higher, generally qualify for tirzepatide therapy. The platform conducts a comprehensive health intake that includes current medications, medical history, and weight loss goals to ensure appropriate candidacy. PlexusDx serves all 50 states without requiring insurance coverage, membership fees, or prior authorization delays.

Patients should disclose any history of pancreatitis, thyroid cancer, or multiple endocrine neoplasia type 2 syndrome, as tirzepatide carries specific contraindications in these populations. A virtual consultation with a PlexusDx-affiliated provider takes approximately 20 to 30 minutes and can be completed from home. Once approved, patients receive their first shipment within 5 to 7 business days, along with detailed injection training materials and ongoing clinical support.

PlexusDx Tirzepatide Injection Options and Pricing

PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan) through three commitment tiers, with the guarantee that your dose may need to go up but your price won't. The medication is produced by licensed 503A compounding pharmacies, which are strictly regulated and subject to rigorous quality standards. Patients can choose weekly or biweekly injection schedules depending on their provider's recommendation, and all doses are formulated to pharmaceutical standards for purity and potency.

Tirzepatide is HSA and FSA eligible at PlexusDx, meaning patients can use pre-tax healthcare savings accounts to cover treatment costs. For those interested in oral forms or combination therapies, PlexusDx also offers oral tirzepatide starting at $349/mo (or $279/mo on the 6-month plan) and the dual-compound GLP-Squared injection (combining semaglutide and tirzepatide) starting at $289/mo (or $249/mo on the 3-month plan). Financial assistance options are available for qualifying patients, and no membership or subscription lock-in is required beyond the initial month.

Personalized Tirzepatide Therapy with Genetic Testing

PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after the first month of treatment, which identifies individual variations in genes that regulate peptide hormone sensitivity and metabolism. The test analyzes key genetic markers including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 to map how your body responds to tirzepatide at the molecular level. This peptide-pathway genetic analysis—distinct from standard pharmacogenomic testing—reveals individual predispositions across 14 metabolic pathways and 49 distinct peptides.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What to Expect During Your First Month on Tirzepatide

Most patients experience initial appetite suppression within 3 to 5 days of their first tirzepatide injection, though the intensity varies based on starting dose and individual metabolism. Common early effects include mild nausea, reduced hunger, and changes in food preferences, particularly toward protein-rich options. These initial adaptations typically resolve within 7 to 14 days as the body acclimate to the medication. Your PlexusDx provider monitors your progress through weekly check-ins during the first month to assess tolerance and determine if dose escalation is needed.

Weight loss during the first month averages 2 to 4 pounds, with more substantial reductions occurring in months two through four as your body adjusts to smaller portion sizes and increased metabolic activity. Keeping a food and symptom journal during this period helps your provider identify any patterns and optimize your treatment protocol. Side effects such as constipation or fatigue can be managed through dietary adjustments and hydration strategies that your PlexusDx care team will recommend. By week four, most patients report improved energy levels and sustained appetite control without medication-related discomfort.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide the same as Mounjaro, and can I get a Mounjaro prescription through PlexusDx?

Tirzepatide is the active ingredient in Mounjaro, which is FDA-approved for type 2 diabetes. PlexusDx provides compounded tirzepatide injections made by licensed 503A compounding pharmacies for weight loss use, which is an off-label application supported by robust clinical evidence. Compounded medications are not FDA-approved but are manufactured under strict pharmaceutical quality standards.

How much weight can I expect to lose on tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What is the cost of tirzepatide through PlexusDx, and does it increase with higher doses?

PlexusDx tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan) across all three commitment tiers. The pricing is flat regardless of dose level—your dose may go up as your body adapts, but your monthly cost remains the same. Treatment is HSA/FSA eligible and available without insurance or membership fees.

What are the most common side effects, and how long do they last?

Nausea, constipation, and mild fatigue are reported by 20 to 40% of patients in the first two weeks and typically resolve by week three. Staying hydrated, eating protein-forward meals, and gradually increasing fiber intake reduce symptom severity. Serious side effects are rare, but patients with personal or family history of pancreatitis or thyroid cancer should discuss tirzepatide with their PlexusDx provider before starting.

How does the Precision Peptide Genetic Test help optimize my tirzepatide therapy?

The test identifies your individual genetic variation in peptide hormone pathways, revealing which patients respond fastest to tirzepatide and which benefit from combination therapy or dose adjustments. PlexusDx analyzes 150+ genetic insights across 14 metabolic pathways to personalize your protocol, potentially accelerating weight loss and reducing side effects. The test costs $99 and can be added after your first month of treatment.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.